The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest oral contraceptive pills market share.

The global oral contraceptive pills market is expected to grow from $20.13 billion in 2022 to $21.61 billion in 2023 at a compound annual growth rate (CAGR) of 7.35%. The oral contraceptive pills market size is expected to grow to $36.09 billion in 2027 at a CAGR of 13.68%.

Major Driver In The Oral Contraceptive Pills Market ­– Increase In The Incidence Of Unintended Pregnancies
Every year, 74 million women in low-middle-income economies have unwanted pregnancies, according to the World Health Organisation (WHO). According to the WHO study, 4,794 women experienced unintended births after stopping taking contraception. As a result, the urge to avoid unexpected births promotes the rise of the market for oral contraceptive tablets.

View More On The Oral Contraceptive Pills Market Report 2023 – https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Key Oral Contraceptive Pills Market Segments
1) By Type: Combination, Progestin Only, Other Types
2) By Category: Generic, Branded
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels

Recent Oral Contraceptive Pills Market Trend – Developing Innovative Solutions
Major institutes and firms in the oral contraceptive pill market are working on producing revolutionary oral contraceptive pill solutions. In July 2022, for example, HRA Pharma, a France-based revolutionary healthcare company, produced an over-the-counter birth control pill named “Opill.” HRA Pharma has submitted an application to the US Food and Drug Administration. Opil is a progestin-based contraceptive that enables patients to obtain contraception without trouble.

Oral Contraceptive Pills Market Prominent Players
Major players in the oral contraceptive pills market are Teva Pharmaceutical Industries Ltd., Bayer AG, Syzygy Healthcare, Mankind Pharma Ltd., Pfizer Inc., Piramal Enterprises Ltd., Ferring B.V, Merck & Co. Inc., Johnson & Johnson, and Lupin Pharmaceuticals Inc.

Request A Sample Of The Global Oral Contraceptive Pills Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3900&type=smp

The Oral Contraceptive Pills Global Market Report 2023  provides a comprehensive overview on the oral contraceptive pills market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the oral contraceptive pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Oral contraceptive pills are contraceptive tablets containing hormones that block egg release from the ovaries. Progestin and oestrogen are commonly found in oral contraceptives. It is also known as the “birth control pill,” since it contains hormones that inhibit eggs from forming in the ovaries. The majority of oral contraceptives contain oestrogen and progestin.

View More Related Reports –
Oral Biologics & Biosimilar Drugs Global Market Report 2023
Oral Thin Films Global Market Report 2023
Oral Biologics And Biosimilars Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model